Larvol Delta - SecondLine-serplulimab-Plus-Anlotinib-and-NabPaclitaxel-for-ESSCLC-After-Firstline-Immunochemotherapy-A-Phase-II-Study-Google-translation

Hetronifly (serplulimab) - Shanghai Henlius Biotech

https://baby.ifeng.com/c/8wPoIJPyHtJ?utm

Sep 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next